Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 246 results for "angel broking ltd"

Buy Crompton Greaves; target of Rs 235: Angel Broking

Angel Broking`s research report on Crompton Greaves For 2QFY2015, Crompton Greaves (CG)'s top-line performance was below our estimates, growing by 7% yoy to Rs3,430cr. On the EBITDA front, the company's margin decline by 10bp yoy to 4.9%, which is ... Moneycontrol.com, 3 days ago
Buy TVS Shrichakra; target of Rs 1040: Angel Broking Moneycontrol.com, 1 month ago
Buy Tide Water; target of Rs 14704: Angel Broking Moneycontrol.com, 1 month ago
Livemint.com

Sebi bars Shri Balaji Investments from capital markets

Sebi today barred Shri Balaji Investments, a certified market representative of Angel Broking, from the capital markets for carrying out illegal trading in shares of various firms such as Tata Power, BHEL, DLF, Punjab National Bank and Reliance ...
 Business Standard India2 months ago PR - Interim order in the matter of Shri Balaji Investments  SEBI2 months ago
Reuters India

Tata Consultancy Q2 earnings misses estimates

October 30, 2014 Tata Consultancy Services Ltd, India's biggest software services exporter, posted a 13.6 percent rise in quarterly net profit, but missed analyst estimates on weakness in outsourcing demand in Latin America and in some ...
 Business Recorder15 hours ago TCS slumps nearly 9 percent, earnings miss estimates  Yahoo! News1 week ago Tata Consultancy second-quarter earnings misses estimates ...  Reuters1 week ago TCS slumps over 8 percent, earnings miss estimates  Business Standard India1 week ago
[x]  
Livemint.com

Ranbaxy posts first profit in 6 quarters

NEW DELHI: Embattled drugmaker Ranbaxy Laboratories Ltd posted its first profit in six quarters on the back of the successful launch of Valsartan, the generic version of Swiss innovator Novartis' blockbuster blood pressure drug Diovan, in the US.
 Economic Times1 day ago Ranbaxy posts Rs478 crore profit in Q2; shares jump 6.11% [Mint, New Delhi :: ]  BusinessWeek2 days ago Ranbaxy posts net profit of Rs478 crore  Livemint.com1 day ago

Banking stocks gallop ahead

Related to : Yes Bank Ltd,Axis Bank Ltd,Kotak Mahindra Bank Ltd Yes Bank Ltd BSE 27 Oct 14 | 12:00 AM 643.50 22.45 (3.61%) NSE 27 Oct 14 | 12:00 AM 643.95 23 (3.7%) Banking shares continued at their upward march on Monday with ...
 Business Standard India3 days ago HDFC's net rises in single digit after 21 quarters  Business Standard India1 week ago UltraTech Cement's profit beats estimates  Business Standard India1 week ago Tyre stocks in demand; Ceat surges 10%  Business Standard India1 month ago
Livemint.com

Sebi ban increases DLF default risk

Mumbai: DLF Ltd may be forced to sell some of its prized assets to avoid default on loans after the company was barred from raising funds through the capital markets, upsetting the nation's biggest property developer's plan to cut debt through ...
 Livemint.com2 days ago DLF: Regulatory developments to remain an overhang  Business Standard India2 weeks ago

Muhurat Trading Session at Bombay Stock Exchange in the Vikram Samvat Year 2071

BSE Ltd. (formerly known as Bombay Stock Exchange) welcomed the Vikram Samvat Year 2071 with much fanfare and panache. The Lakshmi Pooja and the Muhurat Trading Session on Thursday, October 23, 2014 from 6.15 p.m. to 7.30 p.m. was graced by a lot of ...
 Noodls6 days ago Muhurat Trading Session at BSE in the Vikram Samvat Year 2071  India Infoline1 week ago

Yuri Milner to fund half of Housing.com's $40M fundraise

Mumbai-based Locon Solutions Pvt Ltd, owner of real estate portal Housing.com (earlier Housing.in) is in advanced talks to raise $40 million (close to Rs 246 crore) in funding, sources close to the development informed Techcircle.in. Of this, half ...
 VC Circle1 week ago

Infosys Q2 results: Should you buy the stock now?

Related to : Infosys Ltd Infosys Ltd BSE 10 Oct 14 | 01:54 PM 3891.50 245.95 (6.75%) NSE 10 Oct 14 | 01:45 PM 3890.20 243.4 (6.67%) Infosys, which surpassed expectations by announcing a 1:1 bonus issue and its financial ...
 Business Standard India2 weeks ago Infosys hits record high  Business Standard India2 weeks ago

Aurobindo Pharma becomes fifth most valuable pharma firm

Related to : Aurobindo Pharma Ltd Aurobindo Pharma Ltd BSE 07 Oct 14 | 10:29 AM 992.20 26.55 (2.75%) NSE 07 Oct 14 | 10:15 AM 994.80 28.55 (2.95%) Aurobindo Pharma has surged 21% in the past one week, making it the fifth-most ...
 Business Standard India3 weeks ago Sun Pharma: Is the Street's nervousness justified?  Smart Investor1 month ago FDA's Surprise Visit To Sun Pharmaceutical Industries Ltd's Pressures Stock  BioSpace1 month ago Sun Pharma, Ranbaxy extend fall on US FDA's surprise plant inspection  Smart Investor1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less